Medical Manufacturing: Tax Credits for U.S. Production
A senate committee must act next: committee consideration.
While there is broad interest in bringing manufacturing back to the U.S., this specific bill currently lacks bipartisan support and faces a long path through the Finance Committee.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Companies that manufacture medicines, medical devices, or active pharmaceutical ingredients inside the U.S. could claim a tax credit worth 10.5 percent of qualifying income, plus additional credits for buying new equipment. Smaller domestic manufacturers in this niche industry could use these credits to offset costs, though the wage-based cap and equipment cost requirements may favor firms with more capital.
“the domestic medical and drug manufacturing credit determined under this section for any taxable year is an amount equal to 10.5 percent of the lesser of--”
Read twice and referred to the Committee on Finance.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Senators Marco Rubio and Brad Wenstrup introduced the ONSHORE Manufacturing Act on July 15, 2026, aimed at reshoring the production of essential medicines. The bill establishes a 10.5% tax credit for income from domestic manufacturing and a 30% credit for advanced manufacturing equipment.
Congressman Tony Wied (R-WI) introduced the Restoring American Manufacturing (RAM) Act on July 16, 2026. The legislation complements broader onshoring efforts like the ONSHORE Manufacturing Act by providing resources for small businesses to move production facilities back to the United States.
Lawmakers have proposed the ONSHORE Manufacturing Act to reduce reliance on foreign suppliers for critical healthcare items. The bill offers a 10.5 percent tax credit for companies making essential medicines in the U.S. and a 30 percent credit for purchasing advanced manufacturing equipment.
No votes or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
ONSHORE Manufacturing Act
Analysis generated by AI. Always verify with official sources.